Increased expression of tumor necrosis factor-α messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase

被引：54

作者：

Akazawa, A ^{[1
]}

Sakaida, I ^{[1
]}

Higaki, S ^{[1
]}

Kubo, Y ^{[1
]}

Uchida, K ^{[1
]}

Okita, K ^{[1
]}

机构：

[1] Yamaguchi Univ, Sch Med, Dept Gastroenterol & Hepatol, Ube, Yamaguchi 7558505, Japan

来源：

JOURNAL OF GASTROENTEROLOGY | 2002年 / 37卷 / 05期

关键词：

tumor necrosis factor-alpha messenger RNA; inflammatory bowel disease; quantitative RT-PCR;

D O I：

10.1007/s005350200048

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Background Tumor necrosis factor-alpha (TNF-alpha), may be involved in the pathogenesis of inflammatory bowel diseases (IBDs). The aim of this study was to evaluate the effect of TNF-alpha on the inflammatory activity of IBD. Methods. TNF-alpha mRNA expression in intestinal mucosal biopsy specimens from IBD patients [ulcerative colitis (UC), n = 54; and Crohn's disease (CD), n = 11] was analyzed using a competitive polymerase chain reaction. The degree of macrophage infiltration was analyzed by immunohistochemistry, using an antihuman CD68 antibody. Results. TNF-alpha mRNA expression was increased in UC patients, corresponding to the inflammatory activity. However, in CD, TNF-alpha mRNA expression was not correlated with the endoscopic findings. Conclusions. We clarified that TNF-alpha mRNA expression was responsible for the inflammatory activity in UC. However, TNF-alpha mRNA expression was not correlated with the mucosal injury in CD.

引用

页码：345 / 353

页数：9

共 38 条

[31] CYTOKINES IN INTESTINAL INFLAMMATION - PATHOPHYSIOLOGICAL AND CLINICAL CONSIDERATIONS [J].

SARTOR, RB .

GASTROENTEROLOGY, 1994, 106 (02) :533-539

[32] CLONING AND EXPRESSION IN ESCHERICHIA-COLI OF THE GENE FOR HUMAN-TUMOR NECROSIS FACTOR [J].

SHIRAI, T ;

YAMAGUCHI, H ;

ITO, H ;

TODD, CW ;

WALLACE, RB .

NATURE, 1985, 313 (6005) :803-806

[33] NONPARAMETRIC EQUIVALENT OF WILLIAMS TEST FOR CONTRASTING INCREASING DOSE LEVELS OF A TREATMENT [J].

SHIRLEY, E .

BIOMETRICS, 1977, 33 (02) :386-389

[34] TUMOR-NECROSIS-FACTOR-ALPHA INTERLEUKIN-1-BETA, AND INTERLEUKIN-6 EXPRESSION IN INFLAMMATORY BOWEL-DISEASE [J].

STEVENS, C ;

WALZ, G ;

SINGARAM, C ;

LIPMAN, ML ;

ZANKER, B ;

MUGGIA, A ;

ANTONIOLI, D ;

PEPPERCORN, MA ;

STROM, TB .

DIGESTIVE DISEASES AND SCIENCES, 1992, 37 (06) :818-826

[35] CORTISONE IN ULCERATIVE COLITIS - FINAL REPORT ON A THERAPEUTIC TRIAL [J].

TRUELOVE, SC ;

WITTS, LJ .

BRITISH MEDICAL JOURNAL, 1955, 2 (OCT29) :1041-1048

[36] TREATMENT OF CROHNS-DISEASE WITH ANTITUMOR NECROSIS FACTOR CHIMERIC MONOCLONAL-ANTIBODY (CA2) [J].

VANDULLEMEN, HM ;

VANDEVENTER, SJH ;

HOMMES, DW ;

BIJL, HA ;

JANSEN, J ;

TYTGAT, GNJ ;

WOODY, J .

GASTROENTEROLOGY, 1995, 109 (01) :129-135

[37] QUANTITATION OF MESSENGER-RNA BY THE POLYMERASE CHAIN-REACTION [J].

WANG, AM ;

DOYLE, MV ;

MARK, DF .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) :9717-9721

[38] LOCALIZATION OF INTESTINAL INTERLEUKIN-1 ACTIVITY AND PROTEIN AND GENE-EXPRESSION TO LAMINA PROPRIA CELLS [J].

YOUNGMAN, KR ;

SIMON, PL ;

WEST, GA ;

COMINELLI, F ;

RACHMILEWITZ, D ;

KLEIN, JS ;

FIOCCHI, C .

GASTROENTEROLOGY, 1993, 104 (03) :749-758

← 1 2 3 4 →